Medicare Enrolled
Dr. Donald McAlpine, MD
Pulmonary Disease · Cape Coral, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McAlpine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McAlpine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McAlpine
Dr. Donald McAlpine is a pulmonary disease specialist in Cape Coral, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. McAlpine performed 4,226 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McAlpine received a total of $15,575 from 57 pharmaceutical and/or device companies across 683 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McAlpine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 10% volume in FL
$15,575 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 68202 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗4,226
Medicare services
Top 10% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,650 | $94 | $264 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
434 | $65 | $165 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
335 | $33 | $89 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
335 | $43 | $115 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
277 | $31 | $80 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
152 | $8 | $17 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
92 | $107 | $273 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
87 | $10 | $21 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
85 | $8 | $16 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
82 | $129 | $347 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $133 | $370 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
66 | $41 | $105 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
65 | $13 | $27 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
59 | $21 | $55 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
57 | $16 | $34 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $66 | $187 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
44 | $97 | $248 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
33 | $10 | $19 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
33 | $9 | $18 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
30 | $17 | $34 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
26 | $2 | $4 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
26 | $26 | $69 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
22 | $3 | $6 |
| New patient office visit, complex (60-74 min) | 19 | $176 | $458 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
18 | $65 | $177 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
17 | $38 | $79 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $142 | $362 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
15 | $15 | $30 |
| Lung airway biopsy using endoscope A procedure to remove a small tissue sample from the lung airways using a flexible tube with a camera. The sample is examined to check for disease or abnormalities. |
14 | $127 | $721 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $209 | $568 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
11 | $20 | $529 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,575
Total received (2018-2024)
Avg $2,225/year across 7 years
Top 14% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
683
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,131
2023
$5,443
2022
$1,679
2021
$1,933
2020
$1,292
2019
$1,680
2018
$1,417
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$441
Takeda Pharmaceuticals U.S.A., Inc.
$223
Grifols USA, LLC
$180
GlaxoSmithKline, LLC.
$177
Regeneron Healthcare Solutions, Inc.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Insmed, Inc.
$127
Actelion Pharmaceuticals US, Inc.
$106
Xeris Pharmaceuticals, Inc.
$104
Lilly USA, LLC
$55
Tandem Diabetes Care, Inc.
$49
GENZYME CORPORATION
$49
Amgen Inc.
$48
Merck Sharp & Dohme LLC
$43
Electromed, Inc.
$38
ANI Pharmaceuticals, Inc.
$35
Bayer Healthcare Pharmaceuticals Inc.
$29
INTUITIVE SURGICAL, INC.
$26
United Therapeutics Corporation
$23
Abbott Laboratories
$20
Baxter Healthcare
$16
Mallinckrodt Hospital Products Inc.
$16
Novo Nordisk Inc
$15
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$3,361
GlaxoSmithKline, LLC.
$1,778
Grifols USA, LLC
$1,616
AstraZeneca Pharmaceuticals LP
$1,587
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,468
Actelion Pharmaceuticals US, Inc.
$862
Insmed, Inc.
$550
United Therapeutics Corporation
$403
Takeda Pharmaceuticals U.S.A., Inc.
$298
Novo Nordisk Inc
$293
Regeneron Healthcare Solutions, Inc.
$221
Lilly USA, LLC
$188
Merck Sharp & Dohme Corporation
$172
Janssen Pharmaceuticals, Inc
$159
Mallinckrodt Hospital Products Inc.
$146
GENZYME CORPORATION
$141
Tandem Diabetes Care, Inc.
$131
Electromed, Inc.
$130
Amgen Inc.
$130
Xeris Pharmaceuticals, Inc.
$127
Insulet Corporation
$122
Genentech USA, Inc.
$111
Merck Sharp & Dohme LLC
$105
Shire North American Group Inc
$102
ADVANCED RESPIRATORY, INC
$102
Dexcom, Inc.
$100
Baxter Healthcare
$94
Bayer Healthcare Pharmaceuticals Inc.
$91
Bayer HealthCare Pharmaceuticals Inc.
$90
Zealand Pharma US, Inc.
$83
Advanced Respiratory, Inc
$77
Abbott Laboratories
$69
Mallinckrodt Enterprises LLC
$67
Becton, Dickinson and Company
$47
JAZZ PHARMACEUTICALS INC.
$42
Resmed Corp
$41
Genentech, Inc.
$40
Circassia Pharmaceuticals Inc
$40
ANI Pharmaceuticals, Inc.
$35
Sunovion Pharmaceuticals Inc.
$35
Mylan Specialty L.P.
$30
Mallinckrodt LLC
$29
INTUITIVE SURGICAL, INC.
$26
Axsome Therapeutics, Inc.
$25
Acerus Pharmaceuticals Corporation
$22
Novartis Pharmaceuticals Corporation
$21
Corcept Therapeutics
$20
Amarin Pharma Inc.
$19
Amneal Pharmaceuticals LLC
$18
Veran Medical Technologies, Inc.
$17
DEXCOM, INC.
$15
LIFESCAN, INC.
$15
Teva Pharmaceuticals USA, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$14
Antares Pharma, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
Nabriva Therapeutics, plc
$12
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
120V · 60Hz · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirMini · Arikayce · Astral · BAQSIMI · BD Nano · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · DEXCOM G6 TRANSMITTER · DUPIXENT · Da Vinci Surgical System · Dexcom G6 Transmitter · Dymista · EVENITY · Esbriet · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GLASSIA · GVOKE HYPOPEN · HUMULIN · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · ION · JANUVIA · JARDIANCE · Kerendia · Korlym · LONHALA MAGNAIR · Livalo · MOUNJARO · NUCALA · Natesto · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Omnipod · Otrexup · Ozempic · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UNITHROID · UPTRAVI · Utibron · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · WINREVAIR · Wegovy · XARELTO · XOLAIR · Xenleta · Xolair · Yupelri · ZEGALOGUE · ZERBAXA · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
32
County median income
$73,099
Nearest hospital to ZIP centroid (approximate)
CAPE CORAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McAlpine is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McAlpine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McAlpine performed 1,650 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McAlpine receive payments from pharmaceutical companies?
Yes. Dr. McAlpine received a total of $15,575 from 57 companies across 683 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McAlpine's costs compare to other pulmonary diseases in Cape Coral?
Dr. McAlpine's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McAlpine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Cape Coral
Browse pulmonary diseases in Cape Coral ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology